Hobbelen P M, Vogel G M, Meuleman D G
Organon Scientific Development Group, Oss, The Netherlands.
Thromb Res. 1987 Dec 1;48(5):549-58. doi: 10.1016/0049-3848(87)90386-0.
Time response curves of the anti-thrombotic effects, bleeding enhancing effects, effects on APTT, anti-Xa activities, anti-thrombin activities and thrombin generation inhibitory activities of the low molecular weight heparinoid Org 10172 and heparin have been compared in rats. The time courses of these effects were similar for heparin but quite different for Org 10172. Org 10172 induced anti-thrombotic and anti-Xa effects which lasted approximately 3 times longer than those at the same anti-Xa doses of heparin, whereas the bleeding enhancing effects and effects on APTT of Org 10172 were of shorter duration than those of heparin. The half-life of the anti-thrombin effect after Org 10172 seemed somewhat longer than after heparin administration. Thrombin generation inhibition by Org 10172 showed a slightly longer duration than by heparin. The similarities between the time courses of the anti-thrombotic effect and the anti-Xa activity after Org 10172 administration suggest that the most appropriate parameter to monitor Org 10172 treatment is the plasma anti-Xa level.
在大鼠中比较了低分子肝素类似物Org 10172和肝素的抗血栓形成作用、增强出血作用、对活化部分凝血活酶时间(APTT)的影响、抗Xa活性、抗凝血酶活性及凝血酶生成抑制活性的时间反应曲线。肝素的这些效应的时间进程相似,但Org 10172的却截然不同。Org 10172诱导的抗血栓形成和抗Xa效应持续时间比相同抗Xa剂量的肝素长约3倍,而Org 10172的增强出血作用和对APTT的影响持续时间比肝素短。Org 10172给药后抗凝血酶效应的半衰期似乎比肝素给药后稍长。Org 10172对凝血酶生成的抑制作用持续时间比肝素略长。Org 10172给药后抗血栓形成作用和抗Xa活性的时间进程相似,这表明监测Org 10172治疗的最合适参数是血浆抗Xa水平。